SCHEMBL19046264

SCHEMBL19046264

CC1(C)OCC2(CO1)Cc1cc(N=O)c(Cl)cc1O2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23277898 0.80 AKR1B1 (0.34) —
SCHEMBL19045390 0.77 IRAK4 (0.42) —
SCHEMBL19030352 0.76 CYP1A2 (0.40) —
SCHEMBL28240880 0.74 IRAK4 (0.31) —
SCHEMBL19030554 0.73 MAP3K14 (0.33) —
SCHEMBL19030684 0.64 LGMN (0.45) —
SCHEMBL19046313 0.62 ALDH1A1 (0.31) —
SCHEMBL28241753 0.62 ALDH1A1 (0.46) —
SCHEMBL19046261 0.61 IRAK4 (0.48) —
SCHEMBL19030796 0.61 MAPT (0.45) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10988478-B1 Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators GENENTECH, INC. (US) 2021-04-27 — — US disclosed
WO-2017108723-A2 PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2017-06-29 — — WO disclosed
Send feedback